Zheng Qiu

555 total citations
21 papers, 436 citations indexed

About

Zheng Qiu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zheng Qiu has authored 21 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Zheng Qiu's work include Protease and Inhibitor Mechanisms (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Cancer Mechanisms and Therapy (3 papers). Zheng Qiu is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Cancer Mechanisms and Therapy (3 papers). Zheng Qiu collaborates with scholars based in China, Belgium and Australia. Zheng Qiu's co-authors include Hong Wang, Ke Huang, Jun Cao, Chen Huang, Ghislain Opdenakker, Min Wang, Bruno Gaëta, Haiping Hao, Lin Zhu and Weihua Chu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Applied Microbiology and Biotechnology.

In The Last Decade

Zheng Qiu

20 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zheng Qiu China 9 214 134 70 66 37 21 436
Maryam Darvish Iran 12 221 1.0× 59 0.4× 55 0.8× 81 1.2× 23 0.6× 33 431
Jinghui Lu China 13 227 1.1× 110 0.8× 117 1.7× 109 1.7× 41 1.1× 45 673
Su In Lee South Korea 13 303 1.4× 133 1.0× 52 0.7× 114 1.7× 22 0.6× 51 582
Jean‐Philippe Therrien United States 16 400 1.9× 143 1.1× 87 1.2× 82 1.2× 34 0.9× 28 718
Yuhao Xie China 12 245 1.1× 120 0.9× 36 0.5× 116 1.8× 36 1.0× 33 512
Siyi Li China 12 351 1.6× 112 0.8× 120 1.7× 85 1.3× 27 0.7× 48 837
Xue Wan China 12 257 1.2× 63 0.5× 65 0.9× 99 1.5× 35 0.9× 32 630
Mozhdeh Zamani Iran 17 407 1.9× 94 0.7× 53 0.8× 111 1.7× 79 2.1× 57 668
Radek Fedr Czechia 13 351 1.6× 147 1.1× 56 0.8× 57 0.9× 16 0.4× 36 591
Sen Han China 14 224 1.0× 65 0.5× 112 1.6× 40 0.6× 16 0.4× 48 491

Countries citing papers authored by Zheng Qiu

Since Specialization
Citations

This map shows the geographic impact of Zheng Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Qiu more than expected).

Fields of papers citing papers by Zheng Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Qiu. The network helps show where Zheng Qiu may publish in the future.

Co-authorship network of co-authors of Zheng Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Qiu. A scholar is included among the top collaborators of Zheng Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Qiu. Zheng Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Sheng, Shulan Su, Yang Pan, et al.. (2025). Chemical structures of Lycii fructus polysaccharides tailored the gut microbiota composition of aged Caenorhabditis elegans. Food Hydrocolloids. 169. 111608–111608.
2.
Ye, Fei, Tingfang Wang, Liyan Xiong, et al.. (2024). Salvianic acid A ameliorates atherosclerosis through metabolic-dependent anti-EndMT pathway and repression of TGF-β/ALK5 signaling. Phytomedicine. 136. 156307–156307. 4 indexed citations
3.
Wang, Cuihong, Jinhui Fan, Tingfang Wang, et al.. (2024). Nanocarriers Loaded with Danshensu for Treating Ischemic Stroke by Reducing Oxidative Stress and Glial Overactivation. ACS Omega. 9(33). 35686–35694. 3 indexed citations
4.
Xu, Jin, Jiapeng Zhang, Zhongyan Liu, et al.. (2023). Performance analysis of a two-stage vapor compression heat pump based on intercooling effect. Case Studies in Thermal Engineering. 51. 103643–103643. 8 indexed citations
5.
Tao, Huimin, Lü Cheng, Lihua Liu, et al.. (2020). A PD-1 peptide antagonist exhibits potent anti-tumor and immune regulatory activity. Cancer Letters. 493. 91–101. 18 indexed citations
6.
Wang, Hong, Weihua Chu, Haiping Hao, et al.. (2018). Chlorogenic acid attenuates virulence factors and pathogenicity of Pseudomonas aeruginosa by regulating quorum sensing. Applied Microbiology and Biotechnology. 103(2). 903–915. 75 indexed citations
7.
Xu, Yifeng, Hong Wang, Juan Zhang, et al.. (2018). A fusion antitumor peptide regulates proliferation and apoptosis of endothelial cells. Amino Acids. 50(8). 1121–1129. 1 indexed citations
8.
Xu, Yifeng, Hong Wang, Fengguo Zhang, et al.. (2018). Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft. Scientific Reports. 8(1). 8426–8426. 38 indexed citations
9.
Xu, Yifeng, Hong Wang, Juan Zhang, et al.. (2017). Discovery of a polystyrene binding peptide isolated from phage display library and its application in peptide immobilization. Scientific Reports. 7(1). 2673–2673. 53 indexed citations
10.
Qiu, Zheng, Xueqing Zhang, Yifeng Xu, et al.. (2017). CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor α based DNA vaccine. Oncology Reports. 37(6). 3441–3448. 6 indexed citations
11.
Zhang, Fang, et al.. (2017). Identification and Characterization of Strychnine-Binding Peptides Using Phage-Display Screening. Protein and Peptide Letters. 24(7). 626–632. 3 indexed citations
12.
13.
Qiu, Zheng, et al.. (2013). Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment. Anti-Cancer Drugs. 24(7). 677–689. 14 indexed citations
14.
Qiu, Zheng, et al.. (2012). Targeting Matrix Metalloproteinases in Acute Inflammatory Shock Syndromes. Combinatorial Chemistry & High Throughput Screening. 15(7). 555–570. 20 indexed citations
15.
Qiu, Zheng, et al.. (2012). Monoclonal Antibodies Against NS1 Protein of Goose Parvovirus. Hybridoma. 31(2). 125–130. 2 indexed citations
16.
Huang, Chen, Ke Huang, Wei Wu, et al.. (2011). STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice. PLoS ONE. 6(10). e25941–e25941. 57 indexed citations
17.
Qiu, Zheng, Ming Yan, Qian Li, et al.. (2011). Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17). Journal of Enzyme Inhibition and Medicinal Chemistry. 27(4). 533–540. 8 indexed citations
18.
Qiu, Zheng, Chris Dillen, Jialiang Hu, et al.. (2009). Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology. 214(9-10). 835–842. 36 indexed citations
19.
Qiu, Zheng. (2006). Effect of blocking STAT3 signaling pathway on growth of human pancreatic cancer cells. Tumori. 1 indexed citations
20.
Huang, Chen, Jun Cao, Ke Huang, et al.. (2006). Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Science. 97(12). 1417–1423. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026